XML 87 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Share Based Compensation (Summary Of Non-Vested Share Award Activity) (Details) - $ / shares
4 Months Ended 8 Months Ended 12 Months Ended
Apr. 30, 2021
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested Vested, Shares     (48,770)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Non-vested Vested, Weighted-Average Grant-Date Fair Value     $ 30.36  
Non Vested Share Awards, Equity Classified [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance     858,000,000  
Non-vested Granted, Shares     331,000,000  
Non-vested Vested, Shares     (284,000,000)  
Non-vested Forfeited, Shares     (44,000,000)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance   858,000,000 861,000,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Grant-Date Fair Value     $ 26,300,000  
Non-vested Granted, Weighted-Average Grant-Date Fair Value $ 0 $ 26.07 45,390,000 $ 3.07
Non-vested Vested, Weighted-Average Grant-Date Fair Value     26,400,000  
Non-vested Forfeited, Weighted-Average Grant-Date Fair Value     25,020,000.00  
Weighted-Average Grant-Date Fair Value   26,300,000 33,540,000  
Non-Vested Share Awards, Liability Classified [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Non-vested Granted, Weighted-Average Grant-Date Fair Value $ 0 $ 0 $ 0 $ 0.75
Performance Based Awards        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance     609,000  
Non-vested Granted, Shares     158,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance   609,000 767,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Grant-Date Fair Value     $ 17.53  
Non-vested Granted, Weighted-Average Grant-Date Fair Value   $ 15.93 38.08  
Weighted-Average Grant-Date Fair Value   $ 17.53 $ 21.77  
Performance Based Awards | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested Granted, Shares   0    
Performance Based Awards | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested Granted, Shares   236,817    
Market-Based Objectives        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested Granted, Shares     100,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Non-vested Granted, Weighted-Average Grant-Date Fair Value     $ 32.90  
Performance-Based Objectives        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Non-vested Granted, Shares     58,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Non-vested Granted, Weighted-Average Grant-Date Fair Value     $ 47.03